TNF-α blockers and carotid intima-media thickness: An emerging issue in the treatment of psoriatic arthritis

Internal and Emergency Medicine

Volumn 7, Issue SUPPL. 2, 2012, Pages 97-98

  Di Minno, Matteo Nicola Dario ^a   Iervolino, Salvatore ^a   Peluso, Rosario ^a   Scarpa, Raffaele ^a   Di Minno, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL WALL THICKNESS; CAROTID ARTERY DISEASE; DRUG ANTAGONISM; HUMAN; LETTER; PSORIATIC ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865718652     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0704-6     Document Type: Letter

References (5)

1. Tam LS, Li EK, Shang Q et al (2011) Tumor necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study. Ann Rheum Dis 70: 705-706.
2. Di Minno MND, Iervolino S, Peluso R et al (2011) Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α (TNF-α)-blockers and traditional disease modifying anti-rheumatic drugs. Arterioscler Thromb Vasc Biol 31: 705-712.
3. Benagiano M, Azzurri A, Ciervo A et al (2003) T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 100: 6658-6663.
4. Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115: 459-467.
5. Coates LC, Cook R, Leeka KA et al (2010) Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care Res 62: 970-976.